Fulgent Genetics Inc reports results for the quarter ended in March - Earnings Summary

Fulgent Genetics

07/05/2021 22:33

* Fulgent Genetics Inc  FLGT.OQ  reported quarterly adjusted
earnings of $6.59​​ per share for the quarter ended in March.
The mean expectation of three analysts for the quarter was
for earnings of $5.86 per share.
* Revenue rose 4,536% to $359.43 million from a year ago​; 
analysts expected $321.51 million.
* Fulgent Genetics Inc's reported EPS for the quarter was
$6.52​.
* The mean earnings estimate of analysts had risen by about 1.9%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Fulgent Genetics Inc shares had fallen by 24.4% this
quarter and gained 40.1% so far this year.
* The company reported quarterly net income of $200.69 million.
* Wall Street's median 12-month price target for Fulgent
Genetics Inc is $86.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated May 7 at 09:33 p.m. GMT. ​All
figures in US Dollars.​